Navigation Links
Nosey Camera Could Bring Relief to 4 Million Brits
Date:10/31/2011

LONDON, October 31, 2011 /PRNewswire/ --

New tools build upon company's minimally-invasive Balloon Sinuplasty™ Platform to improve visualisation capabilities during sinus surgery for the treatment of chronic rhinosinusitis.

Millions of patients in the UK who suffer from nasal and sinus problems could be brought relief by two innovative technologies to help clear nasal blockages.

Sinusitis is the most common sinus related illness in the UK, with around nine million sufferers and is caused when the delicate membranes in the sinus become inflamed, causing a blockage.

The symptoms of sinusitis can include: pressure headaches, facial pain, nasal obstruction, toothache and fatigue.

Two new technologies, the Acclarent Cyclops™ Multi-Angle Endoscope and the Relieva Luma Sentry™ Sinus Illumination System, allow surgeons to navigate the sinus with an exceptional field of vision to check for any blockages or potential problems.

The sinuses are the air spaces behind the bones of the upper face, between the eyes and behind the forehead, nose and cheeks. The sinuses are narrow and tortuous anatomy, and even relatively minor inflammation can present a major obstacle.

Acclarent Cyclops™ Multi-Angle Endoscope and the Relieva Luma Sentry™ Sinus Illumination System allows the surgeon to directly visualise the natural opening of the sinuses, even parts which are just a few millimeters wide, and examine many angles with one scope.

The two innovations were developed by Acclarent, Inc. who also introduced Balloon Sinuplasty™, a technique in which a tiny balloon is guided into the sinuses to help clear blockages in the sinus in an effective manner.

The treatment has been hugely successful and since Balloon Sinuplasty was launched in 2005, more than 120,000 patients have been treated with the medical procedure.

For further information please visit http://www.balloonsinuplasty.co.uk

For more information on chronic sinusitis treatment visit: http://www.balloonsinuplasty.co.uk/sinusitis-facts/chronic-sinusitis-treatment-options/ and for information on sinus surgery visit: http://www.balloonsinuplasty.co.uk/sinusitis-facts/sinus-surgery/

About the Balloon Sinuplasty™ System: Since 2005, more than 120,000 patients have been treated with Balloon Sinuplasty technology in operating rooms and office settings. Acclarent's comprehensive visualisation capabilities enable surgeons to confidently access, dilate and irrigate targeted sinuses throughout every aspect of Endoscopic Sinus Surgery (ESS) with Balloon Sinuplasty technology and provide their patients with minimally invasive options that have been repeatedly proven safe and effective worldwide.

Acclarent, Inc.

Acclarent is a global medical technology company dedicated to the development of innovative products to further meet the needs of ENT surgeons and their patients. Based in Menlo Park, Calif., the company operates as a business unit of Ethicon, Inc., a Johnson & Johnson company.  Through its core technologies and commitment to innovation, Acclarent will continue to advance novel technologies in all areas of ENT. Acclarent markets and sells its products worldwide and its technology has been used by thousands of physicians. For more information about Acclarent, visit http://www.Acclarent.com.


'/>"/>
SOURCE Balloon Sinuplasty(TM)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
2. MEDX Installs Two Next Generation T-Questâ„¢ Compact Gamma Cameras
3. Visionsense Corp Announces 500 Patients Milestone With Neurosurgical 3D Camera at Emory University Hospital in Atlanta, GA
4. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
5. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
6. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
7. Mayo Clinic Study Shows Drug Could Effectively Treat, Prevent the Spread of Breast Cancer
8. St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases
9. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
10. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
11. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Fla. , Dec. 9, 2016  Harmar Mobility, LLC announced ... and a member of the Board of Directors. Photo ... ... Mr. Dawson,s ... development of organizations across a variety of industries. He brings to ...
(Date:12/9/2016)... -- Research and Markets has announced the addition of ... offering. ... global travel vaccines market to grow at a CAGR of 6.83% ... scenario and the growth prospects of the global travel vaccines market ... revenue generated from the sales of various vaccines administered to actively ...
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
Breaking Medicine Technology:
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... Fla. "I used this old family recipe, which is meant to relieve gout and ... it gave me a 12-hour energy boost every time. It relieved what VA doctors ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy ... in New York, NY, on December 3rd, to benefit Holy Name Medical Center's ... annual event, which raised over $1 million - the largest event in the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital ... and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation ... a few hospitals and facilities have earned this distinction. This is the second ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
Breaking Medicine News(10 mins):